CUTANEOUS LEISHMANIASIS IN KUWAIT - CLINICAL-EXPERIENCE WITH ITRACONAZOLE

Twenty-four patients suffering from single or multiple lesions of cutaneous leishmaniasis were included in this study. Most of the lesions were on the extremities. The patients were randomly divided into two groups. Most of the patients in the first group who were given oral itraconazole for a period of 6-8 weeks showed excellent clinical response. On the other hand, only one patient in the second control group who was given placebo showed good clinical improvement. Systemically administered intraconazole may prove to be a valuable modality for the treatment of cutaneous leishmaniasis.